Glycogen Storage Disease Type 6
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Glycogen Storage Disease Type 6

What is the definition of Glycogen Storage Disease Type 6?
Glycogen storage disease type 6 (GSD6) is a genetic disease in which the liver cannot process sugar properly. The liver is responsible for breaking down a substance called glycogen. Glycogen is the stored form of sugar that is made by breaking down carbohydrates. When the liver cannot break down glycogen properly it causes a buildup that is damaging to the body. Symptoms of the disease usually begin in infancy or childhood and include low blood sugar (hypoglycemia), an enlarged liver (hepatomegaly), and an increase in the amount of lactic acid in the blood (lactic acidosis). These symptoms are especially likely to occur when an individual does not eat for a long time. Symptoms tend to improve as people with this disease get older. The disease is especially common in the Mennonite population. GSD6 is caused by genetic changes (changes) in the PYGL gene. The disease is inherited in an autosomal recessive manner. The diagnosis is made based on genetic testing of the PYGL gene. A liver biopsy that tests the function of liver glycogen phosphorylase may be necessary if the results of the genetic testing are inconclusive.
What are the alternative names for Glycogen Storage Disease Type 6?
  • Glycogen storage disease type 6
  • GSD6
  • Glycogen storage disease 6
  • Hers disease
  • Phosphorylase deficiency glycogen-storage disease of liver
Who are the top Glycogen Storage Disease Type 6 Local Doctors?
Elite in Glycogen Storage Disease Type 6
Elite in Glycogen Storage Disease Type 6
Referral may be required
Freiburg, BW, DE 

Sarah Grunert practices practicing medicine in Freiburg, Germany. Ms. Grunert is rated as an Elite expert by MediFind in the treatment of Glycogen Storage Disease Type 6. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Glycogen Storage Disease Type 6, Mitochondrial Trifunctional Protein Deficiency, Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, and 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency.

Experienced in Glycogen Storage Disease Type 6
Internal Medicine
Experienced in Glycogen Storage Disease Type 6
Internal Medicine
1275 E Belvidere Rd Ste 250, 
Grayslake, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robert Gerber is a primary care provider, practicing in Internal Medicine in Grayslake, Illinois. Dr. Gerber is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 6. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Sickle Cell Disease, Phosphoglycerate Mutase Deficiency, Glycogen Storage Disease Type 7, Ureteroscopy, and Bone Marrow Aspiration. Dr. Gerber is board certified in American Board Of Internal Medicine - Internal Medicine (Certified). Dr. Gerber is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Glycogen Storage Disease Type 6
Family Medicine
Experienced in Glycogen Storage Disease Type 6
Family Medicine

Duke Primary Care Croasdaile

1821 Hillandale Rd, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dana Todd is a primary care provider, practicing in Family Medicine in Durham, North Carolina. Dr. Todd is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 6. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Todd is board certified in American Board Of Family Medicine, Family Medicine. Dr. Todd is currently accepting new patients.

What are the latest Glycogen Storage Disease Type 6 Clinical Trials?
GSD VI and GSD IX Natural History

Summary: Collection and review of clinical information related to Glycogen Storage Disease Type VI (GSD VI) OR Glycogen Storage Disease Type IX (GSD IX) generated during clinic visits.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection (EXCESS)

Summary: Participants are being asked to take part in this study because treatment of his or her disease requires a stem cell transplant. Stem cells or mother cells are the source of normal blood cells and lead to recovery of blood counts after bone marrow transplantation. Unfortunately, there is not a perfectly matched stem cell donor (like a sister or brother) for the participant and his or her disease d...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center